Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer

INTRODUCTION: Regorafenib is an oral multikinase inhibitor for the treatment of metastatic colorectal cancer (mCRC). The clinical factors that may affect adherence to regorafenib remain unclear. The aim of this study was to evaluate adherence to regorafenib with mCRC and to identify factors that mig...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Patient Prefer Adherence
Autori principali: Kawakami, Kazuyoshi, Wakatsuki, Takeru, Soejima, Azusa, Kobayashi, Kazuo, Yokokawa, Takashi, Aoyama, Takeshi, Suzuki, Kenichi, Suenaga, Mitsukuni, Yamaguchi, Kensei, Inoue, Ayaka, Machida, Yoshiaki, Hama, Toshihiro
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2019
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6800560/
https://ncbi.nlm.nih.gov/pubmed/31686792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S217835
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi